Ha Noi CPC1 Pharmaceutical JSC (HSTC:DTP) EBITDA Margin % : 0.00% (As of . 20)

View and export this data going back to 2020. Start your Free Trial

What is Ha Noi CPC1 Pharmaceutical JSC EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Ha Noi CPC1 Pharmaceutical JSC's EBITDA for the six months ended in . 20 was ₫0.00 Mil. Ha Noi CPC1 Pharmaceutical JSC's Revenue for the six months ended in . 20 was ₫0.00 Mil. Therefore, Ha Noi CPC1 Pharmaceutical JSC's EBITDA margin for the quarter that ended in . 20 was 0.00%.

Ha Noi CPC1 Pharmaceutical JSC EBITDA Margin % Historical Data

The historical data trend for Ha Noi CPC1 Pharmaceutical JSC's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ha Noi CPC1 Pharmaceutical JSC EBITDA Margin % Chart

Ha Noi CPC1 Pharmaceutical JSC Annual Data

Trend

EBITDA Margin %

Ha Noi CPC1 Pharmaceutical JSC Semi-Annual Data

EBITDA Margin %

Competitive Comparison of Ha Noi CPC1 Pharmaceutical JSC's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Ha Noi CPC1 Pharmaceutical JSC's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ha Noi CPC1 Pharmaceutical JSC's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ha Noi CPC1 Pharmaceutical JSC's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Ha Noi CPC1 Pharmaceutical JSC's EBITDA Margin % falls into.

Save Embed

;

Save Embed

;

Ha Noi CPC1 Pharmaceutical JSC EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Ha Noi CPC1 Pharmaceutical JSC's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %	=	EBITDA (A: . 20 )	/	Revenue (A: . 20 )
	=		/
	=	%

Ha Noi CPC1 Pharmaceutical JSC's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %	=	EBITDA (Q: . 20 )	/	Revenue (Q: . 20 )
	=		/
	=	%

Ha Noi CPC1 Pharmaceutical JSC (HSTC:DTP) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Ha Noi CPC1 Pharmaceutical JSC EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Ha Noi CPC1 Pharmaceutical JSC's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ha Noi CPC1 Pharmaceutical JSC Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ha Noi CPC1 Pharmaceutical JSC (HSTC:DTP) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ha Binh Phuong Industrial Cluster, Van Binh Commune, Thuong Tin District, Hanoi, VNM

Website

https://www.cpc1hn.com.vn

Ha Noi CPC1 Pharmaceutical JSC is an investment holding company. The company's business activities include the Manufacture of cosmetics, soaps, detergents, polishes, and sanitary preparations; Producing drugs, pharmaceutical chemicals, and pharmaceutical materials; Manufacturing functional, nutritional, and health care foods, and Research and development of natural and academic sciences.